10-16982616-A-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001081.4(CUBN):​c.4563T>A​(p.Ile1521Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.844 in 1,612,786 control chromosomes in the GnomAD database, including 587,786 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 43738 hom., cov: 32)
Exomes 𝑓: 0.86 ( 544048 hom. )

Consequence

CUBN
NM_001081.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.65

Publications

17 publications found
Variant links:
Genes affected
CUBN (HGNC:2548): (cubilin) Cubilin (CUBN) acts as a receptor for intrinsic factor-vitamin B12 complexes. The role of receptor is supported by the presence of 27 CUB domains. Cubulin is located within the epithelium of intestine and kidney. Mutations in CUBN may play a role in autosomal recessive megaloblastic anemia. [provided by RefSeq, Jul 2008]
CUBN Gene-Disease associations (from GenCC):
  • Imerslund-Grasbeck syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • proteinuria, chronic benign
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Imerslund-Grasbeck syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 10-16982616-A-T is Benign according to our data. Variant chr10-16982616-A-T is described in ClinVar as Benign. ClinVar VariationId is 299480.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.65 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.887 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CUBNNM_001081.4 linkc.4563T>A p.Ile1521Ile synonymous_variant Exon 31 of 67 ENST00000377833.10 NP_001072.2 O60494

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CUBNENST00000377833.10 linkc.4563T>A p.Ile1521Ile synonymous_variant Exon 31 of 67 1 NM_001081.4 ENSP00000367064.4 O60494
CUBNENST00000438254.1 linkn.129T>A non_coding_transcript_exon_variant Exon 2 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.734
AC:
111487
AN:
151936
Hom.:
43739
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.456
Gnomad AMI
AF:
0.986
Gnomad AMR
AF:
0.702
Gnomad ASJ
AF:
0.825
Gnomad EAS
AF:
0.534
Gnomad SAS
AF:
0.785
Gnomad FIN
AF:
0.851
Gnomad MID
AF:
0.829
Gnomad NFE
AF:
0.893
Gnomad OTH
AF:
0.767
GnomAD2 exomes
AF:
0.770
AC:
193439
AN:
251130
AF XY:
0.789
show subpopulations
Gnomad AFR exome
AF:
0.447
Gnomad AMR exome
AF:
0.559
Gnomad ASJ exome
AF:
0.824
Gnomad EAS exome
AF:
0.541
Gnomad FIN exome
AF:
0.850
Gnomad NFE exome
AF:
0.889
Gnomad OTH exome
AF:
0.815
GnomAD4 exome
AF:
0.856
AC:
1249822
AN:
1460732
Hom.:
544048
Cov.:
45
AF XY:
0.857
AC XY:
622493
AN XY:
726774
show subpopulations
African (AFR)
AF:
0.437
AC:
14610
AN:
33460
American (AMR)
AF:
0.574
AC:
25656
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.826
AC:
21581
AN:
26126
East Asian (EAS)
AF:
0.501
AC:
19894
AN:
39678
South Asian (SAS)
AF:
0.796
AC:
68646
AN:
86218
European-Finnish (FIN)
AF:
0.854
AC:
45521
AN:
53302
Middle Eastern (MID)
AF:
0.815
AC:
4695
AN:
5764
European-Non Finnish (NFE)
AF:
0.900
AC:
999504
AN:
1111122
Other (OTH)
AF:
0.824
AC:
49715
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
8273
16546
24819
33092
41365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21222
42444
63666
84888
106110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.733
AC:
111518
AN:
152054
Hom.:
43738
Cov.:
32
AF XY:
0.731
AC XY:
54309
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.456
AC:
18900
AN:
41446
American (AMR)
AF:
0.701
AC:
10712
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.825
AC:
2863
AN:
3470
East Asian (EAS)
AF:
0.533
AC:
2746
AN:
5154
South Asian (SAS)
AF:
0.786
AC:
3780
AN:
4812
European-Finnish (FIN)
AF:
0.851
AC:
9020
AN:
10600
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.893
AC:
60735
AN:
67982
Other (OTH)
AF:
0.768
AC:
1620
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1230
2460
3691
4921
6151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.840
Hom.:
17739
Bravo
AF:
0.703
Asia WGS
AF:
0.661
AC:
2303
AN:
3478
EpiCase
AF:
0.887
EpiControl
AF:
0.888

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Imerslund-Grasbeck syndrome type 1 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Imerslund-Grasbeck syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
8.1
DANN
Benign
0.78
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801229; hg19: chr10-17024615; COSMIC: COSV108229690; API